Aeon Biopharma Inc (AEON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 4,016 | -153,473 | 74,150 | 34,727 | 286,342 |
| Operating Income | -4,016 | 153,473 | -74,150 | -34,727 | -286,342 |
| Other Income | -2,155 | 10,639 | -43,868 | 8,485 | -39,030 |
| Pre-tax Income | -6,171 | 164,112 | -118,018 | -26,242 | -325,372 |
| Net Income Continuous | -6,171 | 164,112 | -118,018 | -26,242 | -325,372 |
| Net Income | $-6,171 | $164,112 | $-118,018 | $-26,242 | $-325,372 |
| EPS Basic Total Ops | -11.24 | 304.00 | -227.87 | -97.93 | -630.22 |
| EPS Basic Continuous Ops | -11.24 | 303.91 | -227.83 | -98.37 | -629.93 |
| EPS Diluted Total Ops | -11.24 | 304.00 | -227.87 | -97.93 | -630.22 |
| EPS Diluted Continuous Ops | -11.24 | 303.91 | -227.83 | -98.37 | -629.93 |
| EPS Diluted Before Non-Recurring Items | -11.51 | -11.51 | -20.14 | -51.08 | N/A |
| EBITDA(a) | $-3,991 | $153,497 | $-74,125 | $-34,703 | $-286,315 |